December 27, 2019

Melinta Therapeutics, Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 07, 2020

    Judge Finds No Fraud In Vote For Melinta's Ch. 11 Plan

    Emphasizing that she found no fraud in vote-handling or counts prior to confirmation of antibiotic developer Melinta Therapeutics' Chapter 11 reorganization in April, a bankruptcy judge in Delaware declined Tuesday to reconsider a recent denial of stockholder requests to revoke the plan.

7 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS